Q4 2024 · 13F-HR
Pale Fire Capital SEholdings as filed
Filed 2025-02-13 · accession 0000921895-25-000399
$440.8M
Reported value
51
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 11777Q209 | BTG | B2GOLD CORP | $127.9M | 29.0% | 52,419,026 | Common | SHARED |
| 399473206 | GRPN | GROUPON INC | $123.7M | 28.1% | 10,181,070 | Common | SHARED |
| G27907107 | DOLE | DOLE PLC | $83.9M | 19.0% | 6,198,640 | Common | SHARED |
| Y41053102 | INSW | INTERNATIONAL SEAWAYS INC | $18.6M | 4.22% | 517,264 | Common | SHARED |
| 67066G104 | NVDA | NVIDIA CORPORATION | $13.8M | 3.14% | 103,000 | PUT | SHARED |
| 152006102 | CGAU | CENTERRA GOLD INC | $12.9M | 2.93% | 2,272,798 | Common | SHARED |
| N90064101 | QURE | UNIQURE NV | $10.3M | 2.33% | 580,708 | Common | SHARED |
| G9108L173 | TEN | TSAKOS ENERGY NAVIGATION LTD | $8.3M | 1.89% | 479,288 | Common | SHARED |
| 00183L102 | ANGI1EUR | ANGI INC | $7.7M | 1.75% | 4,642,024 | Common | SHARED |
| 44955L106 | IAUX | I-80 GOLD CORP | $4.9M | 1.12% | 10,179,770 | Common | SHARED |
| 825690100 | SSTK | SHUTTERSTOCK INC | $3.9M | 0.88% | 127,151 | Common | SHARED |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $3.8M | 0.86% | 444,813 | Common | SHARED |
| Y62267409 | NMM | NAVIOS MARITIME PARTNERS L P | $3.7M | 0.83% | 84,351 | Common | SHARED |
| 16934Q802 | CIM | CHIMERA INVT CORP | $2.1M | 0.47% | 149,191 | Common | SHARED |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $1.9M | 0.42% | 525,756 | Common | SHARED |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.7M | 0.38% | 136,897 | Common | SHARED |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $1.5M | 0.33% | 315,154 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $1.2M | 0.26% | 734,204 | Common | SHARED |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $1.0M | 0.23% | 1,401,964 | Common | SHARED |
| 87918A105 | TDOC | TELADOC HEALTH INC | $1.0M | 0.23% | 111,452 | Common | SHARED |
| Y7542C130 | STNG | SCORPIO TANKERS INC | $756,878 | 0.17% | 15,232 | Common | SHARED |
| N0731H103 | ATAI | ATAI LIFE SCIENCES NV | $661,545 | 0.15% | 497,402 | Common | SHARED |
| 45790W108 | — | INOZYME PHARMA INC | $605,347 | 0.14% | 218,537 | Common | SHARED |
| 23256X407 | HELP | CYBIN INC | $537,244 | 0.12% | 60,912 | Common | SHARED |
| 16934W106 | CMRXEUR | CHIMERIX INC | $370,728 | 0.08% | 106,531 | Common | SHARED |
| 001228501 | MITT | AG MTG INVT TR INC | $340,493 | 0.08% | 51,202 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $287,675 | 0.07% | 38,875 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $259,278 | 0.06% | 3,369 | Common | SHARED |
| 92539P101 | — | VERVE THERAPEUTICS INC | $252,672 | 0.06% | 44,800 | Common | SHARED |
| 282559103 | ETNBGBP | 89BIO INC | $238,033 | 0.05% | 30,439 | Common | SHARED |
| 15102K100 | CELC | CELCUITY INC | $228,525 | 0.05% | 17,458 | Common | SHARED |
| N44445109 | IMTX | IMMATICS N.V | $223,695 | 0.05% | 31,462 | Common | SHARED |
| 76200L309 | RZLT | REZOLUTE INC | $211,616 | 0.05% | 43,187 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $205,276 | 0.05% | 5,496 | Common | SHARED |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $202,796 | 0.05% | 16,006 | Common | SHARED |
| 649604840 | ADAM | NEW YORK MTG TR INC | $165,444 | 0.04% | 27,301 | Common | SHARED |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $145,798 | 0.03% | 41,420 | Common | SHARED |
| M96088105 | URGN | UROGEN PHARMA LTD | $133,125 | 0.03% | 12,500 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $132,918 | 0.03% | 43,723 | Common | SHARED |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $125,036 | 0.03% | 32,309 | Common | SHARED |
| G4766E116 | INDV | INDIVIOR PLC | $124,312 | 0.03% | 10,001 | Common | SHARED |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $105,938 | 0.02% | 16,100 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $103,740 | 0.02% | 39,000 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $97,822 | 0.02% | 14,710 | Common | SHARED |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $91,715 | 0.02% | 15,235 | Common | SHARED |
| 75901B107 | RGNX | REGENXBIO INC | $90,603 | 0.02% | 11,721 | Common | SHARED |
| 125525584 | — | CREATIVE MEDIA & CMNTY TR | $89,280 | 0.02% | 396,801 | Common | SHARED |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $82,395 | 0.02% | 18,310 | Common | SHARED |
| 00218A105 | ASPI | ASP ISOTOPES INC | $53,001 | 0.01% | 11,700 | Common | SHARED |
| 64782A107 | NEWP | NEW PAC METALS CORP | $49,713 | 0.01% | 42,130 | Common | SHARED |
| 68828E809 | ODV | OSISKO DEVELOPMENT CORP | $46,440 | 0.01% | 28,491 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.